DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Avage (Tazarotene) - Summary



(tazarotene) Cream, 0.1%

AVAGE® Cream is a white cream and contains the compound tazarotene; this formulation of tazarotene cream is also marketed for the treatment of plaque psoriasis and acne vulgaris as TAZORAC® (tazarotene) Cream, 0.1%.

(To understand fully the indication for this product, please read the entire INDICATIONS AND USAGE section of the labeling.)

AVAGE® (TAZAROTENE) Cream 0.1% is indicated as an adjunctive agent for use in the mitigation (palliation) of facial fine wrinkling, facial mottled hyper- and hypopigmentation, and benign facial lentigines in patients who use comprehensive skin care and sunlight avoidance programs. AVAGE® (TAZAROTENE) Cream 0.1% DOES NOT ELIMINATE or PREVENT WRINKLES, REPAIR SUN-DAMAGED SKIN, REVERSE PHOTOAGING, or RESTORE MORE YOUTHFUL or YOUNGER SKIN.

  • AVAGE® (TAZAROTENE) Cream 0.1% has NOT DEMONSTRATED A MITIGATING EFFECT on significant signs of chronic sunlight exposure such as coarse or deep wrinkling, tactile roughness, telangiectasia, skin laxity, keratinocytic atypia, melanocytic atypia, or dermal elastosis.
  • AVAGE® (TAZAROTENE) Cream 0.1% should be used under medical supervision as an adjunct to a comprehensive skin care and sunlight avoidance program that includes the use of effective sunscreens (minimum SPF of 15) and protective clothing.
  • Neither the safety nor the effectiveness of AVAGE® (TAZAROTENE) Cream 0.1% for the prevention or treatment of actinic keratoses, skin neoplasms, or lentigo maligna has been established.
  • Neither the safety nor the efficacy of using AVAGE® (TAZAROTENE) Cream 0.1% daily for greater than 52 weeks has been established, and daily use beyond 52 weeks has not been systematically and histologically investigated in adequate and well-controlled trials. (See WARNINGS section.)

See all Avage indications & dosage >>


Media Articles Related to Avage (Tazarotene)

Intestinal perforation: New surgical method not better than old
Source: Colorectal Cancer News From Medical News Today [2015.10.27]
A new and simpler surgical method for the treatment of intestinal perforation (laparoscopic lavage) is a poorer alternative for patients compared to the old method (primary resection), researchers...

more news >>

Published Studies Related to Avage (Tazarotene)

Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris. [2010.05]
This 16-week study evaluated once-daily tazarotene 0.1% cream and adapalene 0.3% gel in patients with moderate-to-severe acne. Patients treated with tazarotene 0.1% cream performed better in many acne efficacy measures (reduction in lesion counts, percentage of patients achieving a 50 percent lesion count reduction, overall disease severity, investigator's global assessment) than did patients treated with adapalene 0.3% gel...

Comparative efficacy and safety results of two topical combination acne regimens. [2009.07]
Combination therapy has become the standard for the management of acne, particularly for moderate-to-severe cases... Both treatment regimens were well-tolerated.

Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. [2007.12.01]
PURPOSE: To evaluate the ability of either oral minocycline, topical tazarotene or both, to reduce or prevent cetuximab-related acneiform rash when administered starting on day 1 of cetuximab therapy... CONCLUSION: Prophylaxis with oral minocycline may be useful in decreasing the severity of the acneiform rash during the first month of cetuximab treatment. Topical tazarotene is not recommended for management of cetuximab-related rash.

Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris. [2007.07.13]
Topical retinoids are the cornerstone of therapy for acne vulgaris...

Tolerability comparison of adapalene gel, 0.3% versus tazarotene cream, 0.05% in subjects with healthy skin. [2007.06]
BACKGROUND: Topical retinoids, including adapalene and tazarotene, are a primary treatment choice for patients with acne. Adapalene is currently marketed in a 0.1% concentration in gel and cream formulation. A new gel containing a higher concentration (0.3%) of adapalene has been developed. In clinical studies, adapalene 0.1% concentration has proven to be better tolerated than other retinoids in skin treatment. However, the tolerability of adapalene gel 0.3% has yet to be compared to other topical retinoids. PURPOSE: The purpose of this study was to compare the local cutaneous tolerability of adapalene gel 0.3% once daily versus tazarotene cream 0.05% once daily... CONCLUSION: Adapalene gel 0.3% is very well-tolerated with good cosmetic acceptability.

more studies >>

Clinical Trials Related to Avage (Tazarotene)

Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris [Completed]
This is a safety, tolerability and pharmacokinetics study of AGN-190168 in subjects with acne vulgaris.

A Study Comparing Tazarotene Cream 0.1% to Tazorac� and Both to a Placebo Control in the Treatment of Acne Vulgaris [Completed]

Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis [Recruiting]

A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris [Completed]
The purpose of this study is to assess systemic exposure of a new foam formulation of tazarotene, 0. 1% compared with Tazorac Gel, 0. 1%. The study design and dosing regimen are based on previous clinical studies with Tazorac Gel and Tazorac Cream.

Differin Gel x12 Wks vs Tazorac Cream x12 Wks vs Differin x6 Wks Switched to Tazorac x6 Wks for Treatment of Acne [Completed]
To determine the efficacy and safety of 12 weeks of treatment with Differin Gel, 0. 1% compared to 12 weeks of treatment with Tazorac Cream, 0. 1% and compared to 6 weeks treatment with Differin Gel, 0. 1% followed by 6 weeks of treatment with Tazorac Cream

more trials >>


Based on a total of 7 ratings/reviews, Avage has an overall score of 8. The effectiveness score is 8.29 and the side effect score is 7.43. The scores are on ten point scale: 10 - best, 1 - worst. Below are selected reviews: the highest, the median and the lowest rated.

Avage review by 42 year old female patient

Overall rating:  
Effectiveness:   Highly Effective
Side effects:   Mild Side Effects
Treatment Info
Condition / reason:   Hormonal Acne/Sun Damage
Dosage & duration:   Apply to affected area once daily (dosage frequency: once daily) for the period of 7 months
Other conditions:   n/a
Other drugs taken:   n/a
Reported Results
Benefits:   Skin is clear smooth and brite. Best it has looked in years
Side effects:   initial breakouts worsen, peeling, dryness, redness, burning for the first few weeks and then got better.
Comments:   The first few weeks were horrible with bad break outs, dryness, burning, redness, Peeling, It was a nightmare. Almost gave up on it but my dr would not let me. I then started using a moisteriser right after washing my face and then waited 1/2 hour to 1 hour before the Taz. Symptoms eased up and now my skin is beautiful. This stuff Rocks. Don't give up and keep it off of your lips!


Avage review by 44 year old female patient

Overall rating:  
Effectiveness:   Moderately Effective
Side effects:   Mild Side Effects
Treatment Info
Condition / reason:   Hyperpigmentation
Dosage & duration:   Apply sparingly every other day (dosage frequency: every other day) for the period of 6 months
Other conditions:   brown spots, wrinkles
Other drugs taken:   40+ SPF Daily Sunscreen
Reported Results
Benefits:   Moderate lightening of hyperpigmentation, smoothing of fine lines and wrinkles
Side effects:   Significant peeling of skin around nose and chin, very flakey and noticable, along with all over redness on cheeks, nose and chin.
Comments:   At night, applied pea size amount of cream after cleansing face. Significant peeling around the mouth and nose, so avoided these areas except 1x per week. Peeling would subside after skipping 1 to 2 days of treatment, so initially used 3x per week until skin became adapted to it. To minimize peeling, daily mild exfoliation of the skin really helped. While my hyperpigmentation is not completely gone, I am pleased with the tone of my skin and the minimized wrinkles.


Avage review by 45 year old female patient

Overall rating:  
Effectiveness:   Marginally Effective
Side effects:   Moderate Side Effects
Treatment Info
Condition / reason:   dark spots
Dosage & duration:   once a day (dosage frequency: once a day) for the period of one year
Other conditions:   Dark freckles probably associated with pregnancy.
Other drugs taken:   none
Reported Results
Benefits:   I didn't notice dramatic results with this product and it was fairly expensive at $100 for one tube. I wasn't religious about applying it each day, so that might have had an impact on the effectiveness. I didn't notice significant fading of the darkest large freckles on my face as I had hoped. I didn't notice any significant reduction in wrinkles.
Side effects:   I did not experience any burning sensations with this product in the first week or there after. The product did make my face peel significantly the following day and this occured even with the use of an exfoliating facial wash each morning.
Comments:   I applied the product to my face in the morning OR evening and did it in combination with other typical facial sunscreen products and mosterizers. Since the product was expensive and made my face peel, I tended to apply it only on the dark freckles I was trying to fade.

See all Avage reviews / ratings >>

Page last updated: 2015-10-27

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015